Trimetazidine hydrochloride belongs to other anti angina cardiovascular drugs. It protects the energy metabolism of cells under hypoxia or ischemia and prevents the decline of intracellular ATP level, so as to ensure the normal function of ion pump and the normal operation of transmembrane sodium potassium flow, and maintain the stability of intracellular environment.